PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8222584

Thyroid imaging techniques.

C C Reading·C A Gorman
View original source ↗Export metadata ↓

Abstract

Nuclear medicine, ultrasound, CT, and MRI are imaging methods that can be used to evaluate the thyroid gland. All these techniques give structural information about the thyroid gland and show the location and size of thyroid nodules. Nuclear medicine scanning also adds functional information about nodules. In many practices, however, FNA has supplanted imaging methods as the primary method of thyroid nodule evaluation because it is safe, inexpensive, and results in a better selection of patients for operation. Imaging studies are very useful in the setting of recurrent thyroid cancer. Ultrasound is extremely sensitive in the detection of recurrent malignancy in regional cervical lymph nodes and as a guide in performing a biopsy of these nodes. CT is very useful in identifying distant metastases in the chest and abdomen. Nuclear medicine scanning can detect functioning distant metastases when the metastases are from differentiated thyroid cancers. MRI can be used to evaluate the possibility of recurrent thyroid cancer; however, because of its relatively high cost, it is used less frequently than other imaging methods.

Explore related subjects

Biopsy, NeedleDiagnostic ImagingHumansMagnetic Resonance ImagingRadionuclide ImagingThyroid DiseasesThyroid GlandThyroid NeoplasmsTomography, X-Ray ComputedUltrasonographyJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C C Reading, C A Gorman. 1993. Thyroid imaging techniques.. https://pubmed.ncbi.nlm.nih.gov/8222584/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1996

Analysis of numerical aberrations of specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer.

BACKGROUND: Biopsy by fine-needle, aspiration has become a routine technique for the diagnosis of a dominant breast mass. In this study, fluorescent in situ, hybridization (FISH) analysis of interphase nuclei allowed the authors to detect genetic aberrations that are difficult to identify by conventional cytology. METHODS: To investigate ways of minimizing misdiagnosis of the cytology of breast tumors, and detecting genetic aberrations preoperatively, the authors performed FISH with specimens obtained by fine-needle aspiration biopsies of 106 primary breast tumors (78 primary breast cancers, 2 phyllodes tumors, and 26 benign breast tumors). Numerical chromosome aberrations were investigated using 3-color FISH performed with (peri)centromere-specific probes for chromosomes 1, 11, and 17. RESULTS: Sufficient materials for FISH analysis were obtained with aspiration biopsy from 98 of the 106 breast tumors (93.4%). None of the benign tumors nor phyllodes tumors showed evidence of aneusomy for any of the 3 chromosomes. However, 71 of the 74 breast cancers (95.9%) for which sufficient material was available demonstrated aneusomy of at least 1 of the 3 chromosomes tested. The FISH analysis also suggested a possible correlation between aneusomy of chromosome 17 and metastasis to regional lymph nodes (chi-square test = 7.78; P < 0.05). CONCLUSIONS: FISH analysis of fine-needle aspiration biopsies can be a practical and useful method for the preoperative diagnosis of breast carcinoma.

Biopsy, Needle↗
PubMed1996

Do prostate specific antigen and prostate specific antigen density enhance the detection of prostate carcinoma after initial diagnosis of prostatic intraepithelial neoplasia without concurrent carcinoma?

BACKGROUND: Prostatic intraepithelial neoplasia (PIN) is considered to be a precursor of prostate carcinoma in which serum levels of prostate specific antigen (PSA) have been correlated with PIN grades. The aim of this study was to determine whether PSA and prostate specific antigen density (PSAD), obtained at the time of initial diagnosis of PIN without concurrent carcinoma, can be used as predictive factors to discriminate patients with subsequent cancer on repeat biopsy. METHODS: We studied, retrospectively, the records of 93 patients with PIN (low and high grade) without concurrent carcinoma at the time of their first needle biopsy. We assessed the relationship between initial PIN grade, PSA, and PSAD with later detection of carcinoma on repeat biopsy. Patients were divided into 3 subgroups for analysis according to their initial PSA level (0-4, 4.1-10, >10 ng/mL). RESULTS: Carcinoma detection rate on repeat biopsy was 13.3% for patients with low grade PIN and 47.7% for patients with high grade PIN (P < 0.006). High grade PIN was frequently associated with subsequent carcinoma whatever the PSA level (33.3-61.9%). Low grade PIN was associated with subsequent carcinoma in 42.8% of the cases when PSA was greater than 10 ng/mL. When PSA was between 4 and 10 ng/mL, low grade PIN carcinoma was found on repeat biopsies in only 10.7% of the cases (P = 0.05). In none of the PSA subgroups did PSAD enhance later cancer detection. CONCLUSIONS: For patients with high grade PIN, the incidence of subsequent carcinoma is high, whatever the PSA values. For these cases repeat biopsies should be recommended. Patients with low grade PIN and PSA greater than 10 ng/mL should have repeat biopsies because the incidence of subsequent carcinoma is high and comparable to high grade PIN. PSAD did not provide additional information.

Biopsy, Needle↗